The knockdown of NEAT1 negatively affects the expression of AXIN1, a target of miR-212_3p reversing the suppression effect [179], meaning that the deregulation of this lncRNA is associated with PD development, characterizing it as a candidate therapeutic target. This evidence concerns the gene NEAT1 and Parkinson disease.